Randomised controlled trial of postnatal sodium supplementation on oxygen dependency and body weight in 25-30 week

G Hartnoll1, P Bétrémieux, N Modi

  • 1Section of Paediatrics and Neonatal Medicine, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN.

Insights

Delaying sodium supplementation in preterm infants (25-30 weeks gestational age) until 6% birthweight loss is achieved may reduce oxygen dependency without impacting growth. This finding is crucial for optimizing care for vulnerable newborns.

Area of Science:

  • Neonatalogy
  • Pediatric critical care
  • Perinatal medicine

Background:

  • Preterm infants, particularly those between 25-30 weeks of gestational age, are at high risk for electrolyte imbalances and respiratory complications.
  • Sodium supplementation is a common practice in neonatal care, but the optimal timing remains debated.

Purpose of the Study:

  • To investigate the impact of early versus delayed sodium supplementation on oxygen dependency and body weight in preterm infants.
  • To compare the clinical outcomes associated with different sodium supplementation strategies.

Main Methods:

  • Randomized controlled trial involving preterm infants (25-30 weeks gestational age) stratified by gender and gestation.
  • Infants were assigned to receive sodium supplementation on day 2 or after achieving 6% birthweight loss.
  • Key parameters monitored included serum sodium, fluid and energy intake, oxygen requirement, and body weight at various postmenstrual ages.

Main Results:

  • Delayed sodium supplementation was associated with a significantly lower risk of continuing oxygen requirement at the end of the first week and at 28 days.
  • While the delayed group experienced greater maximum weight loss, there were no significant differences in growth parameters at 36 weeks or 6 months postmenstrual age.
  • Early sodium supplementation and lower birthweight were significantly linked to a higher risk of prolonged oxygen dependency.

Conclusions:

  • Delaying sodium supplementation until at least 6% of birthweight is lost offers a potential benefit in reducing the risk of ongoing oxygen requirements in preterm infants below 30 weeks gestation.
  • This delayed approach does not appear to compromise infant growth and development.
  • The findings suggest a revised strategy for sodium management in this vulnerable population.
Abstract